Expression of Fas ligand on bile ductule epithelium in biliary atresia - A poor prognostic factor

Journal of Pediatric Surgery

Volumn 35, Issue 11, 2000, Pages 1591-1596

  Liu, Chinsu ^a,b   Chiu, Jen Hwey ^a,b   Chin, Taiwai ^a,b   Wang, Liang Shun ^a,b   Li, Anna Fen Yau ^a,b   Chow, Kuan Chih ^a,b   Wei, Choufu ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Biliary atresia; Fas; Fas ligand

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

APOPTOSIS; BILE DUCT ATRESIA; CLINICAL ARTICLE; COMMON BILE DUCT CYST; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; LIVER TUMOR; MONOCYTE; PORTOENTEROSTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0033759420     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1053/jpsu.2000.18322     Document Type: Conference Paper

References (25)

1. Fas involvement in Ca2+-independent T cell-mediated cytotoxicity
2. Fas and its ligand in a general mechanism of T cell mediated cytotoxicity
3. Two different pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes
4. Cytolytic T cell cytotoxicity is mediated through perforin and Fas lytic pathways
5. Role of Fas ligand in apoptosis induced by hepatitis C virus infection
6. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of human necrosis factor
7. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells
8. Fas-mediated cytotoxicity by freshly isolated natural killer cells
9. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage
10. Essential roles of the Fas ligand in the development of hepatitis
11. Biliary atresia: Current concepts and research directions. Summary of a symposium
12. The present status and problems in the treatment of biliary atresia
13. A long-term experience with biliary atresia-reassessment of prognostic factors
14. Long-term outcome after surgery for biliary atresia - Study of 40 patients surviving for more than 10 years
15. The inflammatory response in pediatric biliary disease: Macrophage phenotype and distribution
16. Degeneration of intrahepatic bile duct with lymphocyte infiltration into biliary epithelial cells in biliary atresia
17. Biliary atresia - An autoimmune mediated disorder?
18. Different expression of HLA-DR and ICAM-1 in livers from patients with biliary atresia and Byler's disease
19. Hepatic overexpression of MHC class II antigens and macrophage-associated antigens (CD68) in patients with biliary atresia of poor prognosis
20. Association between HLA and extrahepatic biliary atresia
21. Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis
22. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis
23. Expression of DNA topoisomerase Iia and multidrug resistance p-glycoprotein in acute leukemia
24. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
25. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas